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Abstract 
Endo T is a deglycosylating enzyme secreted by the filamentous fungus Trichoderma reesei (Hypocrea 
jecorina). The active Endo T protein is both deglycosylated and C-terminal processed. Since the intact 
protein was never observed in the T. reesei culture medium, a construct of the intact Endo T was 
expressed in P. pastoris. Here, the glycosylated, intact and inactive protein was found in the medium but 
this form is slowly converted to the deglycosylated and proteolytic cleaved form. The structure of the 
active Endo T was already solved in previous work. We tried to solve the structure of the intact inactive 
Endo T to compare it with the active structure. Several structures of Endo T were solved, but none of 
them were structures of the intact Endo T. Different pH and T parameters were screened to find a 
condition where the C-terminal peptide was stable and the enzyme kept intact. A protease inhibitor 
cocktail was also added to limit the proteolytic process. We were able to control the proteolysis with the 
help of the protease inhibitor cocktail at pH 5 and higher, but we were not able to limit the proteolysis at 
pH 3, nor in any of the crystallization samples.  
Keywords 
Endo T, glycoside hydrolase family 18, EC 3.2.1.96, deglycosylation, proteolysis, C-terminus, protein 
structure. 
 
2 
 
1 Introduction 
Endo T is an endo-N-acetyl-β-D-
glucosaminidase (ENGase) secreted by the 
filamentous fungus Trichoderma reesei. It is an 
enzyme that hydrolyzes the β1-4 bond 
between two acetyl glucosamine residues in 
high-mannose N-glycans. Glycosylation is an 
important post-translational modification 
involved in protein folding mechanisms and 
important for protein stability. ENGases are 
present in eukaryotes as part of the ERAD 
degradation pathway of misfolded proteins. 
Especially with prokaryotes ENGases are often 
involved in parasitism (Karamanos 1997). Endo 
T from T. reesei is responsible for the extensive 
deglycosylation observed for its cellulases and 
other secreted proteins, but its biological role is 
still unclear.  
Endo T has been expressed both homologously 
in Trichoderma reesei and heterologously in 
Pichia pastoris. The P. pastoris expressed 
protein is secreted as an intact protein, fully 
glycosylated but inactive form, while the T. 
reesei expressed protein has lost 9 and 49 
amino acids at its N- and C-terminus 
respectively and contains single N-acetyl 
glucosamine attached to Asn 70 and Asn 240 of 
the protein. This lower molecular weight enzyme 
form is catalytically active and hydrolyzes the 
β1-4 bond in the chitobiose core of high 
mannose N-glycans. These can be bound on a 
glycoprotein or a glycopeptide, but the enzyme 
also acts on free N-glycans.  
Endo T has EC classification 3.2.1.96 and is 
classified as a glycoside hydrolase (GH) family 
18 enzyme. GH18 enzymes are retaining 
glycoside hydrolases using neighboring group 
participation with Asp and Glu as the catalytic 
residues. These two catalytic residues are 
conserved throughout the entire GH 18 family.  
Previously the structure of the active Endo T 
expressed in T. reesei, both with and without 
ligand has been solved to a resolution of 1.3 Å 
The aim for this master project was to solve the 
structure of the intact and presumably inactive 
form of Endo T. This new structural knowledge 
about Endo T will help us to better understand 
how and why Endo T is activated. Solving the 
structure of the intact Endo T might be 
problematic. First off all it is possible that the C-
terminal peptide and/or the N-glycans are too 
flexible to be visible in the electron density map 
for the protein. The second problem, originates 
from previous observations that the protein is 
very hard to keep intact over an extended period 
of time. The proteolytic cleavage of Endo T is 
difficult to prevent even with a purified protein 
sample. From the moment a little amount of 
active protein is formed, the deglycosylation 
process starts to proceed very fast. The reason 
why the C-terminus of the protein is removed so 
fast is not clear. The fast deglycosylation is due 
to Endo T that is deglycosylating itself. 
2 Literature 
2.1 Expression organisms 
2.1.1 Trichoderma reesei 
Trichoderma reesei is a mesophile filamentous 
fungus from the division of the ascomycota. The 
subdivision is pezizomycotina with 
sordariomycetes as class and hypocreaceae as 
family. Trichoderma is the genus name whereas 
T. reesei is the species name. T. reesei is an 
anamorphous or asexual reproduction form of 
Hypocrea jecorina (Taylor, Spatafora and Berbee 
2006, Harman n.d.). 
T. reesei is known to produce high amounts of 
cellulose-degrading enzymes. This is why 
modified strains of this fungus are commercially 
used for production of cellulases and other 
enzymes that degrade complex plant cell wall 
polysaccharides (Harman n.d., Sharma, et al. 
2009). T. reesei is also of interest for its high 
production of extracellular heterologous proteins 
and is often used as a host organism (Maras, et 
al. 1997, Dienes, et al. 2007, Sharma, et al. 
2009).  
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The T. reesei (hemi)-cellulases are partially of 
interest for 2nd generation bio-ethanol production. 
Instead of using starch or sucrose for the 
production of bio-ethanol it is possible now to use 
cellulose rich plant material as feedstock for the 
production of bio-ethanol (European biofuels 
TECHNOLOGY PLATFORM n.d.). Proteolytic 
degradation is a known cause of cellulase 
degradation, as reported by several groups 
(Dienes, et al. 2007, Hagspiel, Haab and Kubicek 
1989). 
2.1.2  Pichia pastoris 
Pichia pastoris is a methylotropic yeast from the 
division of the ascomycota. The subdivision is 
sacharomycetes with sacharomycetales as 
class and Saccharomycetaceae as family. 
Pichia is the genus name whereas P. pastoris is 
the species name (Taylor, Spatafora and 
Berbee 2006).  
P. pastoris is commonly used as an eukaryotic 
expression host in research for heterologous 
protein expression due to different advantages. 
P. pastoris grows on an inexpensive and simple 
mineral medium. It is capable of generating 
post-translational modifications such as N- and 
O-glycosylation and disulfide bonds (Cregg, et 
al. 2000). It has a strong, inducible promoter 
and secretes few endogenous proteins, which 
makes the downstream processing of 
heterologous secreted proteins much easier 
(Dosanjh 1996, Cereghino and Cregg 2000, 
Cregg, et al. 2000).  
Table 1: Different proteases with their classification. 
 
In most researches where P. pastoris or other 
yeast organisms are used as expression 
organism, proteolytic degradation has been 
observed (Cregg, et al. 2000, Sinha, et al. 
2005).  
2.2 Protease 
2.2.1 Proteases: an introduction 
Proteases, which have EC-classification 3.4, 
hydrolyze the peptide bond. Differentiation of 
the subclass are documented, there are two 
sets of subclass peptidases, the exopeptidases 
(EC 3.4.11-19 and the endopeptidases (EC 
3.4.21-24 and EC 3.4.99). The exopeptidases 
act only near the ends of polypeptide chains, 
while the endopeptidases act in-between the 
polypeptide chains. Both sub-subclasses can be 
differentiated on the basis of catalytic 
mechanism or substrate specificity. Table 1 
gives an overview of different proteases and 
their classification by mechanism; the substrate 
specificity is not shown (Moss, E.C. 3.4 acting 
on peptide bonds n.d.) 
Trypsin and chymotrypsin are serine 
endopeptidases, Trypsin is synthesized as 
trypsinogen, the zymogen from trypsin, is the 
inactive protein that is initially transcribed. It is 
important for a protease to be inactive after 
synthesis. This way it can only act on the 
peptide bond where necessary and won’t digest 
the tissues where it’s synthesized (McDowall 
sd). 
 
 
Subclasses  Mechanism Example EC-classification 
carboxypeptidase    
 amino aminopeptidase I 3.4.11.22 
 serine carboxypeptidase C 3.4.16.5 
 cysteine cathepsin X 3.4.18.1 
 metallo carboxypeptidase A 3.4.17.1 
endopeptidase    
 threonine HslU-HslV peptidase 3.4.25.2 
 serine  trypsin/ chymotrypsin 3.4.21.1 
 cysteine  cathepsin B 3.4.22.1 
 metallo coccolysin 3.4.24.30 
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Trypsinogen activation is autocatalytic, once a 
small fraction of trypsinogen is activated, with 
the help of enteropeptidase to trypsin, trypsin 
will activate the rest of the trypsinogen 
(McDowall sd). Trypsin and chymotrypsin are 
synthesized in the pancreas, where most of the 
secreting proteins are synthesized (McDowall 
sd). Chymotrypsin is activated by trypsin-
catalyzed cleavage (Voet, Voet and Pratt 2006, 
Berg, Tymoczko and Stryer 2006).  
2.2.2 Protease activity in T. reesei 
Proteolytic degradation of T. reesei proteins has 
been described in several researches. Hagspiel 
et al. detected proteolytic degradation of Cel7A, 
Cel7B and an α-galactosidase, which were 
produced by the modified T. reesei strain 
QM9414 (Hagspiel, Haab and Kubicek 1989). 
Eneyskaya et al. showed the presence acid 
protease activity in T. reesei medium on α-
galactosidase, β-glycosidase, Cel7A, Cel7B and 
with a fluorogenic peptide, but the protease itself 
was not identified (Eneyskaya, et al. 1999). 
Selinheimo et al. observed a C-terminal 
processed tyrosinase in T. reesei (Selinheimo, 
et al. 2006). In a more recent study by Stals et 
al. a C-terminal processed endo-N-acetyl-β-D-
glucosaminidase, secreted by T. reesei was 
also detected (Stals, Samyn, et al. 2009).  
Contrary, only few studies have been published 
on the biochemical characterization of T. reesei 
proteases. Dienes et al. identified in 2007 a 
trypsin-like serine protease from this T. reesei 
strain QM9414 (Dienes, et al. 2007). The 
protease activity was shown with zymogram 
analysis. The protease itself was identified by 
mass spectrometry after trypsin digestion. Other 
proteolytic experiments were carried out on BSA 
and Hypocrea jecorina Cel7B. The identified 
protease showed high homology with fungal 
serine protease belonging to peptidase family 
S1 (Dienes, et al. 2007).  
The trypsin-like protease that Dienes et al. 
identified is different in substrate specificity to 
the dibasic endopeptidase activity detected by 
Calmels et al. and Goller et al. in fungi (Goller, 
et al. 1998, Calmels, et al. 1991). Calmels et al. 
found that several secreted proteins in fungi 
were processed after a dibasic motif RR, KK, 
KR and RK (Goller, et al. 1998). Several slightly 
different motifs were also found. Goller et al 
confirmed this later, they used T. reesei Cel7A 
and Cel7B and two of the fungus xylanases to 
identify cleavage motifs in T. reesei. They 
identified RA, ER, RR RK and KR amino acid 
sequence motifs on these proteins (Goller, et al. 
1998). When we compare this to the data of 
Dienes et al., we can see that the serine 
protease cleaves after and arginine or a lysine, 
but doesn’t need a dibasic motif. They found 
that when arginine or lysine was followed by a 
proline, the site was almost never recognized as 
a motif. The substrate specificity of the 
proteolytic cleaved tyrosinase described by 
Selinheimo et al. and the other detected 
proteolytic degradation of proteins was not 
described. The C-terminal processing of an 
endo-N-acetyl-β-D-glucosaminidase secreted by 
T. reesei is in a region and not at one specific 
place in this protein’s amino acid sequence. 
2.2.3 Protease activity in P. 
pastoris 
Proteolytic degradation has been a perpetual 
problem when yeasts are used as expression 
organism for recombinant proteins (Cereghino 
and Cregg 2000). In comparison to other 
expression hosts, the proteases from P. pastoris 
are not well characterized (Sinha, et al. 2005). 
One of the main reasons for the proteolytic 
degradation can be found in the oxidative stress 
and heath shock response due to several 
external factors, such as the change of carbon 
source, pH or temperature change. Oxidative 
stress is in this case a very probable cause, 
since the methanol metabolism in P. pastoris 
demands high oxygen levels and a form 
hydrogen peroxide as by-product (Sinha, et al. 
2005). 
Several factors influencing proteolytic 
degradation in the methylotropic yeast P. 
pastoris have been studied by Sinha et al. with 
recombinant ovine interferon-T (Sinha, et al. 
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2005). The pH is one of those factors; this can 
be explained given that each enzyme and 
protease has a pH-optimum. The use of 
casamino acids can reduce the proteolysis, 
perhaps by acting as a preferential substrate for 
the protease. The effect of the phosphate-level 
on the proteolysis has been studied by Sinha et 
al. (Sinha, et al. 2005). Results from these 
studies proved that the protease activity was 
inversely proportional to the phosphate level. A 
more important factor for the proteolytic activity 
is the oxidative stress when P. pastoris is grown 
on methanol. Methanol, which induces the 
AOX1 promoter for recombinant protein 
expression, creates oxidative stress conditions 
(Cereghino and Cregg 2000). 
These conditions were tested by comparing the 
proteolytic degradation when P. pastoris was 
cultivated on methanol and when P. pastoris X-
33 recombinant cell line was cultivated on 
glycerol as the sole carbon source. Not only the 
overall protease activity was measured, but 
different specific protease activities were 
measured as well. The protease activities that 
were measured when methanol was used as 
substrate were found as well when glycerol was 
used as substrate, but in much more reduced 
levels. This proves that the oxidative stress is a 
very important parameter when recombinant 
proteins are expressed by P. pastoris. A last 
factor influencing proteolytic degradation is 
protease inhibition. Different inhibitors belonging 
to several protease classes were added 
separately and in combination, to determine 
their effect on the proteolytic degradation. Sinha 
et al. found that phenyl methyl sulfonyl fluoride 
(1mM) reduced the total protease activity by 
78% and EDTA (1mM) reduced the activity by 
45%. When a combination of both (1mM) was 
used the protease activity was reduced up to 
94.2%. In increasing of the concentration of the 
inhibitors had no decreasing proteolytic effect 
(Sinha, et al. 2005). The paper by Sinha et al. 
do describe several methods and options to limit 
proteolytic degradation when P. pastoris is used 
as heterologous expression host. 
2.3 Endo-N-acetyl-β-D-
glucosaminidase 
2.3.1 EC classification  
Endo T, expressed by T. reesei, is a mannosyl-
glycoprotein endo-N-acetyl-β-D-
glucosaminidase (ENGase) and has EC-
classificatie 3.2.1.96. The systematic name for 
Endo T is: glycopeptide-D-mannosyl – N4 – (N-
acetyl-D-glucosaminyl)2 – asparagines 1,4 – N – 
acetyl – β –glucosaminohydrolase (Moss, EC 
3.2.1 Glycosidases, i.e. enzymes hydrolysing O- 
and S-glycosyl compounds 1992, Henrissat, 
Bairoch and Davies, Glycoside Hydrolase family 
classification 1998). 
2.3.2 Glycoside Hydrolase family 
classification 
The CAZy database describes the families of 
structurally related catalytic and carbohydrate-
binding modules of enzymes that degrade, 
modify, or create glycosydic bonds (Henrissat, 
Bairoch and Davies, Glycoside Hydrolase family 
classification 1998). Endo-N-acetyl-β-D-
glucosaminidase (ENGase) is found in four 
glycoside hydrolase (GH) families, GH family 
18, 20, 85 and 73. In GH family 18 there are two 
known activities, ENGase (EC 3.2.1.96) and 
chitinase (EC 3.2.1.14) and several other non-
catalytic proteins, such as concanavalin B, 
narbonin and a xylanase inhibitor (Henrissat, 
Bairoch and Davies, Glycoside Hydrolase family 
classification 1998). GH family 85 has only one 
known activity, which is endo-N-acetyl-β-D-
glucosaminidase (EC 3.2.1.96) activity and 
several non-catalytic proteins (Henrissat, 
Bairoch and Davies, Glycoside Hydrolase family 
classification 1998). In GH family 20 two 2-
domain proteins are present containing both a  
ENGase GH 18 module and a … GH 20 
module. GH family 73 has several non-classified 
activities and non-catalytic proteins. Endo-N-
acetyl-β-D-glucosaminidases (EC 3.2.1.96), a β-
1,4-N-acetylmuramoylhydrolase (EC 3.2.1.17) 
and autolysin (EC 3.5.1.28) are also classified in 
the GH family 73 (Henrissat, Bairoch and 
Davies, Glycoside Hydrolase family 
classification 1998). 
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Table 2: Endo-N-acetyl-β-D-glucosaminidase in the different GH families. 
 
(*) Both EndoE and EF0114 enzymes are classified in both GH family 18 and GH family 20 according to the CAZy 
classification of carbohydrate enzymes (Henrissat, Bairoch and Davies, Glycoside Hydrolase family classification 
1998) The reason for this dual classification of these enzymes is due to that EndoE and EF0114 have 2 domains, 
one belonging to GH family 18and the second to GH family 20 (personal communication by B. Henrissat). 
 (**) The structure of Endo T has not been published yet. 
GH family Eukaryotic / 
Prokaryotic 
Protein 
name 
Organism name Uniprot 
code 
PDB 
code 
GH 18 Prokaryotic Endo H Streptomyces plicatus P04067.1 1EDT 
  Endo F1 Elizabethkingia meningoseptica ATCC 33958 P36911.1 2EBN 
  Endo F2 Elizabethkingia meningoseptica ATCC 33958 P36912.1 / 
  Endo F3 Elizabethkingia meningoseptica ATCC 33958 P36913.1 1EOK 
  BT3987 Bacteroides thetaiotaomicron VPI-5482 O07088 / 
  EndoE(*) Enterococcus faecalis HER1044 Q6U890 / 
  EF0114(*) Enterococcus faecalis V583 / / 
  Endo-Fsp Flavobacterium sp. SK1022 P80036 / 
  EndoS Streptococcus pyogenes 40/58 PI Q9PAG4 / 
 Eukaryotic Endo FV Flammulina velutipes D1GA49 / 
  Endo T Hypocrea jecorina C4RA8 (**) 
      
GH 20 Prokaryotic EndoE(*)  Enterococcus faecalis HER1044 Q6U890 / 
  EF0114(*) Enterococcus faecalis V583 / / 
      
GH 73  Prokaryotic Mur2 Enterococcus hirae  ATCC 9790 P39046 / 
  Acm2 Lactococcus lactis subsp. cremoris  MG1363 A2RHZ5 / 
  Auto Listeria monocytogenes EGD-e Q8Y842 3FI7 
      
GH 85 Prokaryotic Endo A Artrobacter protophormiae AKU 0647 Q9ZB22 2VTF 
  Endo-BH Bacillus halodurans C-125 Q9KER4 / 
  Endo-D Streptococcus pneumoniae  Q93HW0 / 
  EndoD Streptococcus pneumoniae TIGR4 Q97S90 2W91 
 Eukaryotic AT3g11040 Arabidopsis thaliana Q9SRL4 / 
  At5g05460 Arabidopsis thaliana Q9FLA9 / 
  Endo-CE Caenerohabditis elegans Bristol N2 Q19089 / 
  Engase1 Homo sapiens Q8NFI3 / 
  Endo-M Mucor hiemalis Q9C1S6 / 
  Endo-LE Solanum lycopersicum / / 
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Table 1 gives an overview of all the different 
endo-N-acetyl-β-D-glucosaminidase found 
within various glycoside hydrolase families, 
with their PDB-code, Uniprot code and 
organism listed. In that table 
2.3.3 Glycoside hydrolase family 
18 
The enzymes classified into GH family 18 were 
initially only coming from prokaryotes. Endo H 
from Streptomyces plicatus (Tarentino, 
Plummer and Maley 1974), Endo F1, F2, F3 
from Elizabethkingia meningoseptica (Trimble 
and Tarentine 1991) and other GH family 18 
ENGases are shown in table 2. Eukaryotic 
ENGases belonging to GH family 18 have only 
been discovered recently. Endo T, from 
Trichoderma reesei (Stals, Samyn, et al. 
2009), and Endo FV, from Flammulina 
velutipes (Hamaguchi, et al. 2010), are the first 
two eukaryotic ENGase found to be classified 
into  in the GH family 18. All ENGases from 
GH family 18 are also shown intable 2. Only for 
four of them, the 3D-structure has been 
determined. Whith Endo T as the only fungal 
ENGase. Typical for them and for al GH family 
18 proteins, is their fold. They all have a (β/α)8 
TIM barrel structure. This structure is shown in 
figure 1 and has the form of a cask, where 
eight β-sheets are placed internally in the 
barrel anti-parallel with 8 external α-helices. 
The 8 β-sheets form an inner circle, around 
which the 8 α-helices form an outer circle. The 
cavity in the inner circle is apolair due to the 
apolair side chains of both the α-helices and β-
sheets. The side chains between the α-helices 
and β-sheets are dominated by Val, Ile and Leu. 
The polar amino acids are localized on the 
surface exposed parts of the barrel, on the top 
or the bottom, where they contribute to the 
solubility or the catalytic activity of the enzyme 
(Branden and Tooze 1999, Voet, Voet. and 
Pratt 2008). A structural comparison between 
the characterized GH 18 ENGases is shown in 
appendix 4. 
 
 
2.4 N-Glycosylation 
2.4.1 N-glycosylation an 
introduction 
Glycosylation, a post-translational modification, 
is involved in immunogenicity, protein folding 
and protein stability (Stanley, Schachter and 
Taniguchi 2009 2nd edition). N-glycosylation is 
the transfer of a specific sugar chain to a 
asparagine residue. The transfer of the N-
glycan by the ER-oligosaccharyltransferase 
only occurs in consensus regions consisting of 
the Asn-x-Ser/Thr motif. X can be any amino 
acid except a Pro (Karamanos 1997). Different 
N-glycans are found between organisms and in 
different cells or tissues, but they can all be 
classified into three types; high-mannose, 
complex and hybrid N-glycans (Stanley, 
Schachter and Taniguchi 2009 2nd edition).  
 
Figure 2: Different N-glycosylation forms (Stanley, 
Schachter and Taniguchi 2009 2nd edition). 
Figure 1: (β/α)8  TIM barrel structure from Endo T 
(Boel 2010) 
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High-mannose glycans consist predominatly of 
mannoses and N-acetyl glucosamines. 
Complex type n-glycans are built of mannose, 
N-acetyl glucosamine, galactose, sialic acid 
and are sub classified according to the number 
of branching points. Hybrid type N-glycans 
typically contains two branches; one of the 
high-mannose type and one of the complex 
type. The different N-glycans are shown in 
figure 2. 
2.4.2 N-glycosylation in 
filamentous fungi 
Filamentous fungi are often used as 
expression organism due to their capability of 
post-translational modifications, such as 
glycosylation (Deshpande, et al. 2008, 
Sharma, et al. 2009). In filamentous fungi N–
glycosylation is important in secretion and 
localization of proteins. Only high-mannose 
glycans are found in filamentous fungi. They 
can though still vary between different 
organisms. The degree of mannosylation can 
vary; from 5-7 mannose residues in e.g. T. 
reesei (Stals, Samyn, et al. 2009) upto 8-9 
mannose in e.g. A. niger and extra other 
modifications (e.g. phosphate, sulphate and 
phosphordiester) can be present (Tsutomu 
Takayanagia 1994, Deshpande, et al. 2008). 
Yeast N-glycans can contain more then 100 
mannoses on one N-glycan (Lehle 1992).  
2.4.3 N-glycosylation in 
Trichoderma reesei 
The glycosylation patterns of protein 
expressed by T. reesei can change depending 
on the cultivation conditions. Other hydrolytic 
enzymes are expressed and secreted in the 
cultivation medium and can be active in the 
correct pH conditions. These exo- and/or 
endoglycosidases can act on the O- and N-
glycans present on the glycoproteins 
(predominantly cellulases). These post-
secretorial modifications of both O- and N-
glycosylations have been studied extensively 
on Cel7A in T. reesei  (Stals, Sandra and 
Geysens, et al. 2004, Stals, Sandra and 
Devreese, et al. 2004). And the activity of a α-
mannosidase, phosphatase and endo-N-
acetyl-β-D-glucosaminidase activity was 
observed (Stals, Samyn, et al. 2009). Two 
genes for endo-N-acetyl-β-D-
glucosaminidases, one intracellular and a 
second extracellular ENGase (Endo T) are 
present in the T. reesei genome (Martinez D 
2008). Endo t was in a later study purified from 
the culture broth an partially characterized 
(Stals, Samyn, et al. 2009). 
2.5 Endo T 
2.5.1 Substrate 
T. reesei Endo T hydrolyzes the β-1,4 
glycosydic bound between the two N-acetyl 
glucosamine (NAG) of high-mannose N-
glycans as described above. Therefore one 
NAG stays bound to the protein after the 
removal of the N-glycan by Endo t. The second 
NAG remains bound to the removed high-
mannose N-glycan (Karamanos 1997). The 
presence of the enzyme in the medium 
explains for the occurrence of single NAG 
residues on T. reesei proteins as reported by 
several groups (Stals, Sandra and Geysens, et 
al. 2004). 
2.5.2 Mechanism 
Endo T and all ENGases are retaining 
glycoside hydrolases using neighboring group 
participation for the catalytic mechanism. The 
distance between the catalytic residues Asp 
129 and Glu 131 in the retaining mechanism is 
approximately 10 Å. The mechanism is shown 
in figure3. There has to be 1 acetic residue 
being an Asp or Glu and one stabilizing group. 
For all ENGases in GH family 18 the catalytic 
residues are Asp and Glu with only one 
residue between them. The acetic residue 
interacts with the substrate and forms an 
oxazoline intermediate, this is formed after a 
transition state. A second acetic group 
stabilizes the intermediate and brings the 
active site back to its original state (Davies and 
Henrissat 1995).  
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2.5.3 Structure 
The structure of the active form of the endo-N-
acetyl-β-D-glucosaminidase secreted by T. 
reesei, i.e. Endo T, has been solved by X-ray 
crystallographic methods and the structure was 
refined to 1.3 Å. The protein was crystallized 
using a protein concentration of 8.3 mg/ml, in 
0.1 M citric acid buffer, with a pH between 2.4-
3.0 and using PEG 3350 or 
PEG1500/PEG8000 as a precipitant, with both 
PEG concentrations varying from 4 to 14 % 
and by incubating the experiments at 20° C 
(Digre 2010). The tertiary structure of Endo T 
is an (β/α)8 TIM barrel and the structure has 
overal dimensions of appoximately 45 Å x 34 Å 
x 57 Å A cartoon representation of the Endo T 
structure is shown in figure 4.  
 
Figure 4: A cartoon representation of the Endo T 
structure with a ligand bound in the active site of the 
enzyme, on top of the B-barrel. The bound ligand is 
colored yellow, the catalytic residues are colored 
blue and the two bound NAG residues red 
 
 
 
 
 
 
 
 
2.6 X-ray crystallography 
2.6.1 Protein crystallography 
Protein crystallography has been thought to be 
more an art then a science for a very long time 
(Chayen, Turning protein crystalization from an 
art into a science 2004). A lot of patience, 
perseverance, intuition and luck is needed to 
grow high-quality protein crystals (Navarro, Wu 
and Wang 2009). Nowadays more and more 
proteins are routinely crystallized. This is 
mainly due to the high-throughput 
crystallization methods that have been 
developed over the past decade (Chayen, 
Protein crystallization strategies for structural 
genomics 2007).  
 
Figure 5: Protein crystallization phase diagram. The 
different paths are show for the different 
crystallization methods; (1) batch method, (2) vapor 
diffusion, (3) dialysis and (4) free interface diffusion 
(Chayen, Turning protein crystalization from an art 
into a science 2004). 
Figure 3: Retaining mechanism with a N-acetyl or N-glycol group on position 2 (Davies and Henrissat 1995). 
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Proteins molecules in supersaturated state can 
precipitate, nucleate or form crystals. Figure 5 
shows the phase diagram for all these different 
states of a protein. Only after nucleation, 
protein crystals start to be formed and grow. 
Crystal growth occurs in the meta-stable zone, 
shown on Figure 5. It is the level of super-
saturation, which is the main drive for a protein 
to crystallize. For X-ray crystallography big 
high-quality crystals are needed to obtain a 
good x-ray diffraction pattern when the protein 
crystals are exposed to x-ray beam. Massive 
nucleation and precipitation should thus be 
limited (Chayen, Turning protein crystalization 
from an art into a science 2004). Different 
techniques can help to overcome this problem 
when normal methods fail to crystallize 
proteins (Chayen, Methods for seperating 
nucleation and growth in protein crystalization 
2005). Examples of these methods are e.g. 
adding nucleation seeds (both macro and 
micro seeding) to a crystallization drop and 
dilution of the protein solution used for the 
crystallization experiment. The difference 
between macro and micro seeding is that in 
the former one introduce single crystals to the 
crystallization drop while in the later case one 
try to ad controlled amounts of pre-grown 
nucleation sites to the crystallization drop. In 
both cases with the hope that these seeding 
strategies will give raise to bigger and better 
quality crystals of the target protein (Chayen, 
Methods for seperating nucleation and growth 
in protein crystalization 2005).  
Different parameters influence a crystallization 
experiment, these can be categorized in ether 
bio-physical phenomena or crystallization 
methods (Bergfors 1999). Bio-physical 
parameters are for instance protein 
concentration, temperature, pH, the precipitant 
and its concentration, the salt and its 
concentration and so on. Different 
thermodynamic and kinetic parameters for a 
crystallization experiment could in theory be 
calculated, but would create a lot of work and 
these parameters will be different for each new 
protein (Navarro, Wu and Wang 2009).  
The importance of the different crystallization 
methods should not be underestimated. A 
different path to get to the meta-stable zone 
and to grow high-quality crystals characterizes 
each method. These different paths are shown 
in Figure 5 and all of these methods will pass 
the nucleation phase, before dropping to the 
meta-stable zone and crystal growth (Chayen, 
Turning protein crystalization from an art into a 
science 2004). The batch method was the first 
method that was developed for protein 
crystallization. It is an easy and simple method, 
still in use but not so common any longer 
(Bergfors 1999). Various types of so called 
vapor diffusion methods are now more 
commonly used. In the vapor diffusion 
crystallization method different setups are 
available. These different setups are hanging 
drop, sitting drop and sandwich drop and are 
shown in Figure 6. The hanging drop vapor 
diffusion method is commonly used to set up 
manually crystallization experiments. The 
sitting drop method is most often used to setup 
crystallization plates with various types of 
crystallization robots. For the hanging drop 
method a volume of 500 µl is usually used in 
the crystallization experiment reservoir 
containing the crystallization solution. This 
crystallization solution contains buffer 
(concentration often varying between 0.1 and 
0.2 M), metal ions and crystallization 
precipitant, all in different concentrations 
depending on the crystallization condition. One 
of the most commonly used precipitants in a 
protein crystallization experiment are different 
types of poly ethylene glycol (PEG). Their 
average molecular weight can vary.  
 
 
 
 
Figure 6: Different vapour diffusion methods. Hanging 
drop (1), sitting drop (2) and sandwich drop (3) 
method (Bergfors 1999). 
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There are two steps to get high-quality 
crystals. Screening to identify initial 
crystallization conditions is the first step. 
Different companies sell crystallization screens 
that are used to identify the initial crystallization 
condition for the protein of interest. An 
example of a crystallization robot is the Oryx 
robot from Douglas instruments, Hungerford 
(Bergfors, Terese M. 2009). Two examples of 
commercially available crystallization screens 
are; the JCSG or the Core 96 screen and the 
PEG ION screen (HAMPTON 2003, QIAGEN 
2003). Crystallization robots are very useful 
tool to save time and reproduces crystals in a 
higher ratio than manual crystallization setups 
do. 
When initial crystal conditions are found, these 
crystals have to be tested to determine 
whether these crystals are protein or salt 
crystals. If the initial crystals are found to be 
protein crystals the crystallization condition is 
further refined to produce bigger crystals. This 
is the second step in a crystallization process 
and is often called optimization of the 
crystallization condition. Different ways of 
identifying initial crystallization conditions and 
improving this further to produce high quality 
protein crystals are well described in the book: 
“Protein crystallization second edition, edited 
by Terese M. Bergfors”. Other techniques that 
have not been mentioned, can also be found in 
this handbook (Bergfors, Terese M. 2009). 
When protein crystals are big enough to be 
used for an X-ray data collection, these are 
picked out the crystallization drop. The crystal 
is moved to a cryo solution and frozen in liquid 
nitrogen. The function of keeping the crystal 
frozen at a cryogenic condition is to prevent 
that the crystal is thermally destroyed in the 
strong X-ray beams in use today, often strong 
synchrotron X-ray sources To identify a good 
cryo-solution can be very tidies and difficult. 
Therefore several conditions should be tried 
(Bergfors, Terese M. 2009). After freezing the 
crystals, these can be stored in liquid nitrogen 
before being transported to the synchrotron, 
where the crystals will be exposed in the X-ray 
beam. 
2.6.2 X-ray diffraction  
The longest and most difficult part to get a 
good 3D model, is getting high-quality crystals. 
After subjecting the crystal to X-ray’s, the 
diffraction pattern has to be translated in to a 
3D structure model. Depending on the size of 
the protein and the quality of the diffraction 
pattern obtained when exposing the crystal in 
the X-ray beam, solving the structure and 
refining the structure model it is the second 
biggest task. At a synchrotron the protein 
crystals are exposed in an X-ray beam with a 
wavelength of approximately 1 Å. A X-ray data 
collection can consist of anything between 
hundred up to many hundreds images, where 
the oscillation of the crystal in the x-ray beam 
and the exposure time can be adapted to 
achieve as god diffraction as possible from the 
exposed crystal.  
2.6.3 Electron density map 
The first task after a X-ray data collection is to 
translate the diffraction pattern into an electron 
density map. Crystals, which are subjected to 
X-rays, will give a specific diffraction pattern. 
This diffraction is the result of enhanced X-ray 
radiation in some directions and extinguished 
X-ray radiation in other directions. Each 
electron of the atoms building up the molecules 
of the crystal will influence the final diffraction 
pattern obtained, since each reflection will 
change the intensities of other reflections. A 
crystal is a symmetric repetition of the 
molecule building up the crystal, (Lattman and 
Loll 2008).  
Each reflection is characterized by its position, 
amplitude and its phase. Both the amplitude of 
all diffraction spot of a X-ray diffraction dataset 
and the phases information for each of these 
diffraction spots are necessary to know to be 
able solve the three dimensional structure of a 
protein using the diffraction dataset obtained. 
The amplitudes can directly be derived from 
the intensity of the reflection recorded on the 
diffraction image collected when exposing the 
crystal in the x-ray beam. The phases on the 
other hand cannot be derived directly.  
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Several techniques are available to determine 
the phases for the recorded reflections. 
Determination of the phases by isomorphous 
replacement, and phasing with a highly similar 
know structures (molecular replacement) are 
two techniques which are commonly used to 
derive the phase information for the collected 
the collected reflections (Lattman and Loll 
2008). Once the phase information for the 
diffractions spots are known the diffraction 
pattern will be translated into an electron 
density maps. This translation is done by 
computer software 
2.6.4 Protein structures 
A structure model of the protein that is studied 
is modeled into the electron density map 
calculated from the diffraction pattern obtained. 
Refining a protein model is the modeling in of 
the individual amino acids of a protein into the 
calculated electron density map. Usual during 
refinement of a structure two different electron 
density maps are calculated from a diffraction 
pattern, the (2Fo –Fc) and the (Fo-Fc) map.  
The quality of the built structure model 
depends a lot on the on the quality of the 
calculated electron density map and by the 
refinement and fitting of the model in the 
electron density map. The higher resolution of 
the diffraction pattern on can collect, the better 
the electron density map gets. An electron 
density map with a resolution of 3 Å will show 
the main structure elements of the protein, an 
electron density map of approximately 1 Å 
resolution will show the protein studied at 
atomic resolution, including the hydrogen 
atoms of the protein. The higher the resolution 
of a collected diffraction pattern gets, the more 
reflections the collected dataset contains 
(Wlodawer, et al. 2007). A second parameter, 
which is a control for the quality of the protein 
model are the R and Rfree factors. These 
factors measure the difference between the 
observed and calculated amplitudes of the 
electron density. The lower these R-factors are 
the better the quality is. There is though one 
general remark, the value of the R-factors 
cannot keep dropping, they are correlated to 
the quality of the electron density map. The 
lower the difference between the R and Rfree 
the less difference there is between the 
observed and calculated amplitude and the 
better the model is. The angles of the phases 
are also a parameter, which should be 
checked regularly(Wlodawer, et al. 2007).  
The amino acids of a protein are modeled into 
the electron density map calculated from the 
collected diffraction pattern. Not all geometric 
conformations of the peptide bond between 
two connected amino acid in the poly-peptide 
chain of a protein are allowed. Depending on 
the quality of the electron density map, the 
restrains for the geometric parameters for the 
individual amino acids building up a protein 
and the geometric for the angles between two 
connected amino acids in the poly-peptide 
chain can be loosened up gradually, and the 
dependents between the structure model and 
the electron density map can be increased. 
The refinement of a structure model can be 
very time consuming and will depend a lot on 
the resolution and the quality of the calculated 
electron map for the protein. The better the 
phases get, the better the structure model will 
be. The phases for the calculated electron map 
can be improved by adding solvent molecules 
to the structure model in addition to adding the 
amino acids for the protein part of the model. 
Several programs are capable of refining 
structures and they are the perfect tools to 
solve protein structures.  
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3 Materials and methods 
3.1 Protein samples 
The intact Endo T samples were 
heteroloughsly expressed in P. pastoris. A 
mutated Endo T (D129A) protein expressed in 
T. Reesei was also used, but we weren’t able 
to confirm if it was catalytic dead. 
3.2 Endo T protein analysis  
3.2.1 SDS-PAGE analysis 
Samples of expressed and purified Endo T 
proteins were checked using 4-20% (15 well) 
gradient gels or on 12% (15 well) homogenous 
poly-acrylamide gels from Bio-Rad. The gels 
were bought pre-casted from the Bio-Rad. 5 µl 
of the precision standard ladder was loaded on 
gel, while 12 µ l of the treated protein sample 
was loaded. Protein samples were treated by 
adding 5 µ l of SDS dye sample buffer to 15 µ l 
of non-treated protein samples and heated for 
5 minutes at 95°C. The gel was run for 40 
minutes with a SDS containing running buffer 
and washed several times with water before 
being stained. After washing, the gels were 
stained for one hour with Bio-safe G-250 stain 
from Bio-Rad and the gels were destained 
overnight in water. 
3.2.2 Native-PAGE analysis 
Endo T proteins were treated as the SDS-
PAGE analysis, with the only difference that 
the protein sample was loaded untreated. The 
gel was run for 3 hours minutes with native 
running buffer and washed several times with 
water before being stained. After washing the 
gels were stained for one hour with Bio-safe G-
250 stain. 
3.2.3 Peptide fingerprinting by 
mass spectrometry 
Several bands were analyzed with mass 
spectrometry after trypsin digestion, to identify 
if the detected band on the gel corresponded 
to the intact or processed form of Endo T. All 
the mass spectrometry experiments were 
carried out using a Ultraflex MALDI TOF/TOF, 
Bruker Daltonics and carried out by Åke 
Engström at the Department of medical 
biochemistry and microbiology, biomedical 
centre Uppsala, Sweden. 
3.2.4 Western Blot 
SDS-PAGE gels were run in duplicate, one 
was stained as described above, while the 
proteins of the unstained gel were transferred 
on a nitrocellulose membrane as described by 
Burnette (Burnette 1981). After the transfer, 
the bands containing terminal mannoses can 
be detected with the glycan differentiation kit 
from Boehringer Mannheim Biochemica as 
described in the DIG kit procedure 
(Biochemica 1996). But the transfer of the 
proteins to the nitrocellulose filter failed twice. 
The gels are shown in appendix 3. 
3.2.5 Protein concentration 
The absorbance of the Endo T protein sample 
was first measured using a Nanodrop 
spectrophotometer. Samples of 2 µ l protein 
were used to determine the protein 
concentration using the Nanodrop 2000 The 
protein concentration was measured at 280 
nm, and the absorbance at 260 nm was also 
measured to determine the concentration of 
DNA in the sample. The absorbance was then 
used to calculate the protein concentration with 
the specific protein extinction coefficient.  
When a bad 260/280 value was measured, the 
absorbance couldn’t be used to determine the 
total protein concentration of the sample. The 
total protein concentration was then measured 
by using the Bio-Rad protein assay, which is 
based on the Bradford method (Bio-rad n.d.). 
20 µ l of a bovine serum albumin standard 
(from 0 to 0.8 mg/ml) was incubated with 1 ml 
of 5 times diluted dye reagent (diluted in de-
ionized water) at room temperature for 5 
minutes. The same procedure was carried out 
applied for the dilution series of the Endo T 
protein sample. The concentration of the Endo 
T protein samples were then calculated back 
from the absorbance. All measurements were 
conducted in triplicates and measured at 
λ=595 nm. 
14 
 
3.3 Purification of the intact 
Endo T for crystallization 
3.3.1 Size-exclusion purification 
with a 3 kDa cutoff filter. 
The extracellular culture medium from a 500 ml 
Pichia pastoris culture was first Buchner 
filtered to get rid of cell debris. Then the culture 
medium was concentrated with a 3 kDa cutoff 
filter to a final volume of approximately 12 ml in 
20 mM pH 8 Tris buffer, protease inhibitors 
were added to keep Endo T intact. This Endo T 
protein sample was checked on SDS-PAGE. 
Patricia Ntarima conducted the first purification 
steps of Endo T at the university college 
Ghent.  
3.3.2 Superdex 75 size-exclusion 
chromatography 
The intact Endo T with protease inhibitors 
added to the protein solution was purified by 
size-exclusion chromatography. The column 
was first cleaned with water and thereafter pre-
incubated  with 100 mM sodium chloride 20 
mM pH 5 sodium acetate buffer. 500 µl of 9.40 
mg/ml Endo T sample was loaded to the 
column and eluted with 100 mM sodium 
chloride 20 mM pH 5 sodium acetate buffer 
after 15 minutes. The concentration of the 
Endo T was measured using the protein assay 
from Bio-Rad. The fractions from the peaks 
were checked on a 4-20% gradient gel SDS-
PAGE after first being concentrated to 
approximately 750 µ l with a 2 ml Vivaspin 
column with a molecular cutoff filter of 3kDa. 
3.3.3 MonoQ anion exchange 
chromatography 
The monoQ column was first washed with 
water, with 2ml 2M NaCl, 2ml 1 M NaOH, 2ml 
1M HCl and 2 ml of 75 % acetic acid to get rid 
of all impurities before using it. The column 
was cleaned with water and with a strong 
buffer before calibrating the column. The 
calibration of the column was done by first 
running 40 ml 20 mM pH 6.5 Bis-Tris buffer 
and with approximately 40 ml 1 M NaCl 20 mM 
pH 6.5 Bis-Tris buffer. 20 ml 20 mM pH 6.5 
Bis-Tris buffer was brought over the column 
before loading the protein sample on the 
column. 1 ml of Endo T in 20 mM pH 8 Tris 
buffer was diluted in 49 ml of 20 mM of Bis-Tris 
buffer to change the pH to 6.5 and to lower the 
conductivity of the sample. The protein was 
eluted with a linear gradient from 0 % to 100% 
(1 M NaCl 20 mM pH 6.5 Bis-Tris buffer). 
Changing the gradient from 0 % to 70 % gave 
a better separation of the different eluted 
peaks. The peak fractions were concentrated 
with Vivaspin columns with a molecular weight 
cut-off filter of 3kDa and then checked on 12 % 
homogenous SDS-PAGE. The protein 
concentration was determined using the 
Nanodrop. 
3.3.4 Deglycosylation of intact 
Endo T for crystallization 
A sample of intact Endo T, in  20 mM pH 8 Tris 
buffer with protease inhibitors, was buffer 
exchanged against 50 mM pH 5 sodium 
acetate buffer. The sample was then incubated 
at 37°C for approximately couple of days to let 
the active fraction of Endo T present in the 
sample deglycosylated all N-glycans bound to 
the inactive form of Endo T. The results of the 
deglycosylation experiments were checked on 
4-20% gradient SDS-PAGE. The 
deglycosylated fractions could then be used for 
crystallization experiments. 
3.4 Proteolytic stability of the 
intact Endo T 
The protease inhibitor cocktail used is the 
HaltTM Protease Inhibitor Single-Use Cocktail 
EDTA-Free from Thermo Scientific. 10µl of the 
cocktail was added to 1ml of the protein 
sample as described in the protocol for the 
used protease inhibitors. 
3.4.1 pH-stability 
150 µl of Endo T samples with a concentration 
of 9.40 mg/ml, both with and without protease 
inhibitors, were incubated at 21°C in 100 mM 
citric acid buffer pH 3, 100 mM acetic acid 
buffer pH 5, 100 mM TRIS pH 8 and 100 mM 
pH 11.61 citric acid phosphate buffer to check 
their proteolytic pH stability. Six different 
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samples of all pH conditions were taken in a 
period between 5 hours and 14 days after 
incubation and checked on 12% homogenous 
SDS-PAGE. 
3.4.2 Temperature stability 
150 µ l of 100 mM pH 5 sodium acetate buffer 
Endo T samples with a concentration of 9.40 
mg/ml, both with and without protease 
inhibitors, were incubated at 4, 21 and 37 °C to 
check their proteolytic temperature stability. Six 
different samples of all conditions were taken 
in a period of 14 days and checked on 12% 
homogenous SDS-PAGE. 
3.4.3 Proteolytic degradation 
Both the wild type Endo T and the mutant 
Endo T (D129A) were incubated for 1 day at 
20°C in a 0.1M pH 3 citric acid buffer. Protein 
samples were taken at time 0, 2 hours, 6 
hours, and 1 day. A mixture of 1/1 was also 
incubated in the same conditions. The different 
protein samples were then checked on a 12 % 
homogenous SDS-P. 
3.4.1 Proteolytic activity 
Both the wild type Endo T and the mutant 
Endo T (D129A) were incubated for 1 day at 
20°C in 0.1M pH3 citric acid buffer, and 
thereby lose the C-terminus of the protein. 
These samples were then incubated with T. 
reesei Cel7A for 2 hours at 20°C in 0.1M pH3 
citric acid buffer. The incubation was 
performed at different Endo T/Cel7A weight 
ratios of 1/1, 1/10, 1/20, 1/40 and 1/100. The 
non-cleaved and cleaved form of Cel7A, by 
papaine digestion were taken as control 
samples. A 1/1 ratio of both the wild type Endo 
T and the mutant Endo T (D129A) were 
incubated with Cel7A for 2 hours at 20°C in 
0.1M pH3 citric acid buffer, without losing their 
C-terminus. 
3.5 X-ray crystallography 
3.5.1 Protein crystallization 
Crystallizations were setup up at 20°C, both for 
the hanging drop and sitting drop plates. The 
Oryx robot, from Douglas instruments, was 
used to set up crystallizations with the JSCG 
and the PEG ION crystallization screens 
(QIAGEN 2003, HAMPTON 2003). The well 
volume of the crystallization experiments was 
70 µl . The total drop volume of the 
crystallization experiment was 0.70 µl. The 
drop consisted of 0.35 µ l well solution, and of 
0.35 µ l protein sample. When hanging drop 
crystallization plates were setup the well 
volume contained 500 µl and the crystallization 
drop had a final volume of 4µl. The drop 
consisted of 2µl well solution and 2 µ l protein 
sample. The well liquid consisted of a 0.100 M 
buffer, the pH and buffer was varied and PEG 
3350, where the concentration was varied. In 
both setups, the protein concentration was 
varied.  
3.5.2 X-ray diffraction 
The Endo T crystals were transported to the 
synchrotron (MAX-Lab, Lund or ESRF, 
Grenoble) where they were tested in the X-ray 
beam at the synchrotron . The oscillation range 
for the data collection was 1°, and the number 
of images collected depended on the strategy 
used for the data collection. 
3.5.3 Protein structure and 
refinement 
The different protein structures were solved by 
processing all images using the program 
imosflm (Powell 2010). When the collected 
diffraction images were processed, the space 
group of the diffraction pattern had to be 
determined. When this was done. The 
processed diffraction data was then scaled 
with the scala program within the ccp4 
packages (International Union of 
Crystallography 2011). After scaling the 
obtained dataset an already available Endo T 
model was refined against this new dataset. 
Waters and other components were built in to 
the structure model to further improve the 
phases of the electron density map. The R and 
Rfree values, the bond distance and bond 
angles were checked after each refinement run 
to obtain a good structure model.  
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4 Results 
4.1 Endo T protein analysis  
4.1.1 Endo T transport control 
The protein samples with expressed Endo T were 
transported from the University College Ghent to 
SLU, Uppsala; there they were analyzed using a 4-
20% (15 well) gradient SDS-PAGE gel to check if 
the Endo T protein in these were still intact. Both 
the sample with inhibitors and the sample without 
inhibitors did still contain intact Endo T protein after 
transport. If lower bands appear proteolytic 
degradation or deglycosylation takes place. The 
short processed Endo T was also loaded on gel as 
a reference. These results are not shown. 
4.1.2 Protein concentration 
The total concentration of the crude Endo T sample 
with protease inhibitors was approximately 9.40 
mg/ml, the sample without protease inhibitors had a 
concentration of 2.84 mg/ml. These results are 
shown in appendix 1.  
4.2 Purification of the intact 
Endo T for crystallization 
4.2.1 Size exclusion 
chromatography 
Three batches of 0.500 ml Endo T with protease 
inhibitors were purified with a superdex75 
column. The purification by size exclusion failed. 
These results are shown in Figure 7. No further 
purification with this method was used. In the first 
trial no salt was added and the protein was lost, 
in the second trial the protein purification failed 
and in the third trial Endo T got degraded.  
 
Figure 7: Size exclusion chromatography of Endo T 
with protease inhibitors. The first purification (A) 
without any salt in the elution buffer failed and the 
protein was lost. The two other attempts (B and C) 
with salt, failed or the protein got degraded.  
4.2.2 Anion exchange 
chromatography 
A batch of 1 ml Endo T with protease inhibitors 
was purified with anion exchange 
chromatography using a MonoQ column. Figure 
10 shows the chromatogram from the separation 
with a linear gradient of 1 M NaCl from 0 to 70%. 
Different fractions corresponding with the 
different peaks were then checked by SDS-
PAGE, to identify the Endo T fractions 
containing Endo T. These results are shown in 
Figure 11. The separation was very good and 
was even better with a gradient from 0 to 70%. 
The concentrated protein samples are shown in 
appendix 2. 
Figure 8: Protein status of Endo T (undiluted; 10 times and 
100 times diluted) was checked after transport. Lane 2 to 4 
contain the dilution series of the active Endo T, lane 5 to 7 
the Endo T sample without inhibitors and lane 8 to 10 
contain the Endo T sample with inhibitors. 
Lane 2 to 4 :Crude processed Endo T sample 
Lane 5 to 7: Crude intact Endo T sample – inhibitor 
Lane 8 to 10: Crude intact Endo T sample+ inhibitor 
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Figure 11: Different fractions of the first MonoQ 
purification. Lane 2, 3 and 5, 6 contain unpurified Endo T 
as control. Samples 56 to 63 correspond with the first 
small peak. Fraction 68 with peak 1 around 340 ml in 
figure 3 and fractions 71 and 72 with peak 2 around 355 
ml in figure 3. Fraction 86 is from the last peak. These 
fractions were concentrated after purification. 
4.2.3 Deglycosylation of intact 
Endo T for crystallization 
Deglycosylation of the intact Endo T, by the active 
fraction of Endo T, in the unpurified protein sample, 
is shown in Figure 9. During deglycosylation at 37 
°C a pull down of protein was noticed. The sample 
was centrifuged and the supernatant was removed. 
The pull down was resuspended in a 50 mM pH 5 
sodium acetate buffer and also checked on SDS-
PAGE gel. The pull down was identified as Endo T. 
This is though the first time that a pull down of Endo 
T is noticed. 
 
Figure 12: The resulting gel after Native poly-
acrylamide gel run to check if oligomers of Endo T are 
formed. Lane 2 contains the active Endo T, lane 3 en 
4 the intact Endo T, both unpurified (3) and purified 
(4). Lane 6 and 7 contain anion exchange fractions 
(F1Q1 and F2Q2) of the intact Endo T, lane 9 
contains the deglycosylated protein sample shown in 
figure 9. 
Figure 10: Chromatogram of anion exchange chromatography with a MonoQ column and a 1 M NaCl gradient going 
from 0 to 70 %. The gradient consists of 20 mM Bis-Tris pH 6.5 and 1M NaCl 20 mM Bis-Tris pH 6.5. Peak 1 around 
340 ml is the first fraction; peak 2 around 355 ml is the second fraction containing a different form of the intact Endo T. 
1     2 
Figure 9: Deglycosylation of inactive Endo T by the 
active Endo T fraction from the unpurified sample. The 
values between brackets represent the log scale of 
the dilution. Higher bands around 75 kDa, 150 kDa 
and higher than 250 kDa were identified as Endo T. 
       1      2       3    4          6    7           9 
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The deglycosylated sample was incubated with 
protease inhibitors at 37°C in 0.1 M pH 5 sodium 
acetate buffer for over a week and was kept intact. 
After loading the different deglycosylation samples 
on gel, new prominent bands were detected. These 
bands around 75 kDa, 150 kDa and higher than 250 
kDa were cut out and were subjected to mass 
spectrometry for peptide identification. The bands 
were identified as Endo T and could’ve been 
oligomers or highly glycosylated forms of Endo T. A 
native gel was run and no oligomers were visible. 
The concentration used in the Native PAGE is lower 
then the detected Endo T bands around 75 kDa, 
150 kDa and higher than 250 kDa. Because of this 
we cannot conclude whether these higher bands 
are oligomerizations or not. 
4.3  Proteolytic stability of the 
intact Endo T 
4.3.1 T- dependent degradation 
pattern of Endo T 
Proteolytic degradation of intact Endo T by protease 
activity was observed in protein samples incubated 
at different temperatures. In lane 13 of figure 13 
there are 5 bands, proteolytic degradation is 
confirmed when band 4 and/or band 5 is observed. 
At 4°C proteolytic degradation was observed after 8 
days. At 21 °C degradation was observed after 6 
days and at 37 °C already after 3 days. Figure 13 to 
15 show the degradation pattern at the three 
different temperatures. The negative control, the 
Endo T sample with protease inhibitors didn’t work. 
Degradation was detected in samples of Endo T 
with and without protease inhibitors present. The 
reason for this is that the protein sample with 
protease inhibitors was kept in the freezer and it 
was not until a later stage the we realized that the 
protease inhibitors lose their effect when kept 
frozen at -20°C for a longer period of time. No new 
inhibitors were added before setting up the 
experiment. For this reason the negative control 
failed. In previous experiments the protease 
inhibitors had been tested and had worked. 
  
Figure 13: SDS-PAGE showing the degradation pattern 
of Endo T incubated at 4°C in 100 mM pH 5 sodium 
acetate buffer. Samples were taken after 5 hours; 1 day; 
3 days; 6 days; 8 days and 14 days. Lane 1 is the 
molecular ladder, lane 2 to 7 contain the Endo T protein 
sample at the different time points without the protease 
inhibitor cocktail, lane 8 to 13 contains the Endo T protein 
sample at the different time points with the protease 
inhibitor cocktail.  
 
 
Figure 14: SDS-PAGE showing the degradation pattern 
of Endo T incubated at 21°C in 100 mM pH 5 sodium 
acetate buffer. Samples were taken after 5 hours; 1 day; 
3 days; 6 days; 8 days and 14 days. Lane 1 is the 
molecular ladder, lane 2 to 7 contain the Endo T protein 
sample at the different time points without the protease 
inhibitor cocktail, lane 8 to 13 contains the Endo T protein 
sample at the different time points with the protease 
inhibitor cocktail.  
 
 
Figure 15: SDS-PAGE showing the degradation pattern 
of Endo T incubated at 37°C in 100 mM pH 5 sodium 
acetate buffer. Samples were taken after 5 hours; 1 day; 
3 days; 6 days; 8 days and 14 days. Lane 1 is the 
molecular ladder, lane 2 to 7 contain the Endo T protein 
sample at the different time points without the protease 
inhibitor cocktail, lane 8 to 13 contains the Endo T protein 
sample at the different time points with the protease 
inhibitor cocktail. 
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4.3.2 pH-dependent degradation 
pattern of Endo T 
Proteolytic degradation by protease activity was 
observed in all different pH conditions except the 
one at pH 11.63. The samples at this pH are not 
so visible compared to protein samples in other 
conditions. For that reason it is not possible to 
draw a direct conclusion about proteolytic 
cleavage of Endo T at this high pH condition. 
There was both degradation in the sample with 
and without protease inhibitors. The reason 
therefore is described above under Temperature 
-dependent degradation pattern of Endo T. 
Protein degradation is accelerated when pH is 
decreased. Figure 16 to 19, show the 
degradation pattern of Endo T. At pH 3 full 
degradation of the protein is observed after one 
day. A second experiment was setup to give a 
better image of the degradation of Endo T at pH 
3. In this experiment fresh protease inhibitors 
were added to the protein sample before 
incubation. At pH 5 degradation of Endo T 
occurred after 6 days. The same period is 
needed at pH 8, but the amount of degraded 
Endo T is lower than at pH 5. No direct 
conclusion can be drawn about the degradation 
of Endo T incubated at pH 11.6. 
 
 
Figure 16: SDS-PAGE showing the degradation pattern 
of Endo T incubated at 21 °C in 100 mM citric acid buffer 
pH 3. Samples were taken after 5 hours; 1 day; 3 days; 6 
days; 8 days and 14 days. Lane 1 is the molecular ladder, 
lane 2 to 7 contain the Endo T protein sample at the 
different time points without the protease inhibitor 
cocktail, lane 8 to 13 contains the Endo T protein sample 
at the different time points with the protease inhibitor 
cocktail 
 
Figure 17: SDS-PAGE showing the degradation pattern 
of Endo T incubated at 21 °C in 100 mM acetic acid 
buffer pH 5. Samples were taken after 5 hours; 1 day; 3 
days; 6 days; 8 days and 14 days. Lane 1 is the 
molecular ladder, lane 2 to 7 contain the Endo T protein 
sample at the different time points without the protease 
inhibitor cocktail, lane 8 to 13 contains the Endo T protein 
sample at the different time points with the protease 
inhibitor cocktail.   
 
 
Figure 18: SDS-PAGE showing the degradation pattern 
of Endo T incubated at 21 °C in 100 mM Tris buffer pH 8. 
Samples were taken after 5 hours; 1 day; 3 days; 6 days; 
8 days and 14 days. Lane 1 is the molecular ladder, lane 
2 to 7 contain the Endo T protein sample at the different 
time points without the protease inhibitor cocktail, lane 8 
to 13 contains the Endo T protein sample at the different 
time points with the protease inhibitor cocktail.   
 
 
Figure 19: SDS-PAGE showing the degradation pattern 
of Endo T incubated at 21 °C in 100 mM phosphate-citric 
acid buffer pH 11.6. Samples were taken after 5 hours; 1 
day; 3 days; 6 days; 8 days and 14 days. Lane 1 is the 
molecular ladder, lane 2 to 7 contain the Endo T protein 
sample at the different time points without the protease 
inhibitor cocktail, lane 8 to 13 contains the Endo T protein 
sample at the different time points with the protease 
inhibitor cocktail.   
 
 
Figure 20: SDS-PAGE showing the degradation pattern 
of Endo T incubated at 21 °C in 100 mM citric acid 
buffer pH 3. Lane 2 to 5 contains Endo T without 
protease inhibitors added, lane 6 to 9 Endo T with 
protease inhibitors added, lane 10 to 13 Endo T with 
protease inhibitors and PEG added.  
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Figure 20 shows a better degradation pattern at 
pH 3 then figure 16. Samples were taken after 
15 minutes, 2 hours and 15 minutes, 9 hours 15 
minutes and 1 day and 15 minutes. In all three 
conditions there is complete degradation of 
Endo T at pH 3 after only one day. The 
degradation is slower with protease inhibitors 
added, but still occurs. This shows us that the 
inhibitors are not stable or not working at this 
pH. The quality of the gel was not good and 
PEG also influences the quality of the bands on 
SDS-PAGE. This experiment was a control 
since, proteolytic degradation of Endo T 
occurred in a pH 3 crystallization condition.  
4.3.3 Proteolytic degradation in 
crystallization  
Proteolytic degradation of Endo T was observed 
in the initial crystal conditions found. These 
conditions were at pH 2.4 – 3 and as is shown in 
figure 20 the used protease inhibitors are not 
stable at this pH. Some crystals and crystal 
drops were loaded on SDS-PAGE gel to check if 
Endo T was degraded, this is shown in figure 21. 
 
 
Figure 21: SDS-PAGE showing the protein status in 
the crystals (Lane 6 and 7) and in the crystal drops 
(Lane 8 and 9) at pH 3, 100mM citric acid in 5-9% 
PEG 3350. Lane 1 contains the ladder, lane 2 the 
active Endo T, lanes 3 to 5 inactive Endo T protein 
samples Q1F2, Q1F1 and the non-purified Endo T 
protein sample respectively. Both in the crystals and 
the crystal drops of Endo T are proteolytic cleaved to 
their short and active form. 
To see if the proteolytic cleavage of Endo T is 
due to the crystal condition or the protein 
sample, the protein samples were loaded on gel 
to see if they were processed. The protein 
samples with inhibitors were stored for more 
than 3 months in the fridge. Figure 22 shows us 
that all these samples are still very similar to the 
samples taken just after the protein purification. 
 
Figure 22: SDS-PAGE of the Endo T protein 
crystallization samples. With Q2F1 in lane 1; Q2F2; 
Q1F2; Q1F2 and Q2F1 in lanes 3 to 6. Lane 9 and 10 
contain Q1F1 and Q1F2, which were stored in the 
freezer, finally lane 11 and 12 contain the Endo T 
(D129A) mutant undiluted and 10 times diluted. 
The Endo T (D129A) mutant was loaded to 
check if this variant of the protein was 
processed. As shown in lane 12 on figure 22 the 
Endo T mutant is mainly unprocessed. The 
proteolytic degradation pattern of both the wild 
type and the mutant Endo T were then 
compared. These results are not shown. Due to 
an error in dilution, the mutant Endo T was not 
visible on SDS-PAGE. Therefore we cannot 
compare the degradation pattern of the wild type 
and the mutant Endo T.  
4.3.4 Proteolytic activity on Cel7A. 
In a previous paper an acid protease from T. 
reesei, was found to cleave Cel7A and Cel7B 
into their active form (Eneyskaya, et al. 1999). 
Since Endo T loses its C-terminus in acid 
conditions, Endo T was tested to see if it had a 
protease activity. The acid protease previously 
discovered has the same molecular mass as 
Endo T, for these reasons we thought Endo T 
potentially could possess protease activity in 
addition to its ENGases activity. 
Both the wild type and mutant Endo T were 
added in different ratio’s (1/1, 1/10, 1/20, 1/40, 
1/100 and 1/400) to purified intact T. reesei 
Cel7A. All conditions were incubated for 2 hours 
in 0.1 M pH 3 citric acid buffer. Both the 
unprocessed and processed Cel7A, by papain 
cleavage, were added as controls. Cel7A was 
also incubated without Endo T, as a control for 
the low pH. These results are not shown. The 
D129A mutant Endo T was not visible on SDS-
PAGE because of a dilution error. There was 
also no visible protease activity after 2 hours 
incubation in 0.1 M pH 3 citric acid buffer for all 
the different ratios.  
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4.4 Protein crystallization, data collection and structure refinement 
Crystallization conditions for Endo T are shown in table 3. These are the crystallization conditions, on 
which data were collected. The different data collections are shown in table 4. The final statistics for the 
refined Endo T models are shown in table 5. The final table 6, gives the Ramachandran plot for both new 
Endo T structures obtained. 
Table 3: Different crystallization conditions on which data was collected. 
 
Table 4: Data collection on the different crystals shown in table 3. 
Beam line at MAX-lab, Lund, Sweden 
Rmerge = Σhkl Σi⏐I – < I >⏐/ Σhkl Σi ⏐ I ⏐ 
R = Σ ⏐ ⏐Fo⏐– ⏐Fc⏐ ⏐ / Σ ⏐Fo⏐ 
Condition pH 3 pH 6.5 (a) pH 6.5 (b) pH 7.5 
Buffer citric acid Bis-Tris Bis-Tris Hepes 
0.1 M 0.1M 0.1 M 0.1 M 
Precipitant PEG 3350 PEG 3350 PEG 3350 NaPO4, PoPO4 
5-9% 20 % 20 % 0.8M 
Protein MonoQ  MonoQ MonoQ MonoQ 
6-10 mg/ml 8 mg/ml 8 mg/ml 8 mg/ml 
Ion  CaCl2,CdCl2,CoCl2 ZnCl2  
0.02M 0.02M 
Time to appear 3 days 1 month 1 month 1 month 
Crystal     
Condition pH 3 pH 6.5 (a) pH 6.5 (b) pH 7.5 
Beam line I911-3 I911-3 I911-3 I911-3 
Wavelength (Å) 1.300 1.300 1.300 1.300 
No. Of images 140 140 140 140 
Oscillation range (°) 1.0° 1.0° 1.0° 1.0° 
Space group P41 P21 P21 P21 
Cell parameters (a,b,c) 89.19,89.19,148.12 35.64,64.23,59.22  35.52,64.05,59.25  35.65,64.18,59.30 
Resolution range (Å) 35.22-2.40 23.67-1.31 23.58-1.31 23.65-1.40 
Average multiplicity 8.4  2.8 2.8 2.9 
Completeness (%) 100  98.1 98.1 99.6 
R merge (%) 15.2 5.2 6.3 7.2 
I/σ(I) 11.9 11.6 8.5 9.0 
Diffraction     
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Table 5: Final refinement and model statistics. 
 Endo T pH 3 Endo T pH 7.5 
Resolution used in refinement (Å) 146.96 - 2.20 23.65 - 1.40 
Reflections in: working & test set 54497 - 4029 48821 - 3639 
   
Rd & Rfree factor (%) 19.94 – 24.62 13.91 - 16.99 
Protein molecules in Asymmetric unit 4 1 
Residues in protein 291 287 
Protein atoms   10025 2592 
Waters  829 272 
N-glycosylation (NAG) 8 2 
Residues with double conformations 22 14 
   
Average atomic B-factor (Å2): 18.40 14.85 
   
RMSD bond lengths from ideal (Å) 0.0066 0.0085 
RMSD bond angles from ideal (º) 1.1956 1.3161 
   
Ramachandran plot statistics (%)   
           Preferred regions 95.81 95.56 
           Allowed regions 3.30 2.67 
           Outliers 0.89 0.76 
   
Correlation coefficient Fo-Fc (%) 92.9 97.5 
Correlation coefficient Fo-Fc free (%) 89.4 96.3 
 
Table 6: Ramachandran plot (coot) for the final refined Endo T structures. 
Endo T pH 3 Endo T pH 7.5 
 
 
 
All four crystallization conditions were solved; the pH 3 and pH 7.5 conditions were refined with their final 
refinement parameters in table 5. All structures were completely similar to previously solved structures, 
except the structure from the pH 3 condition. In this condition the N-terminus is both longer and in a 
different conformations in comparison to the three structures. The same protein and protein concentration 
was used in all 4 conditions. There was no difference between the structures at the C-terminus.
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4.5 Structural comparison 
4.5.1 Comparison to known 
proteins 
A structural comparison between the active 
Endo T and all structural characterized endo-
N-acetyl-β-D-glucosaminidases (Endo F1, F3 
and Endo H) has been carried out in a 
previous MSc study (Digre 2010). In this study 
the differences in the active site of Endo T (T. 
reesei), Endo H (S. plicatus) and Endo F3 (E. 
meningoseptica) was described. The 
comparison of the overall structure of Endo T 
with other ENGases from GH family 18 has 
been made more recently. This comparison is 
shown in appendix 4. It was previously 
mentioned in this thesis that Endo T potentially 
also could have a protease activity in addition 
to its ENGases activity. Since Endo T loses its 
C-terminus very fast at acidic conditions. An 
acid protease from T. reesei with the same 
molecular mass as Endo T was described in a 
previous article (Eneyskaya, et al. 1999) Endo 
T was tested to have a protease activity and 
screened for a protease active site in the 
structural comparison shown in appendix 4. 
 
Figure 23: The region in the protein sequence with 
the possible catalytic protease site in the structurally 
characterized ENGases. Potential catalytic amino 
acids in the sequence are colored yellow. 
Since the structure of the active Endo T was 
solved, it was scanned for different protease 
active site motifs. One potential protease 
active site was site found, which has the 
sequence catalytic triade for a serine protease. 
The distances in the structure are not optimal, 
but proteins are known to be flexible. The 
serine and histidine residue of this potential 
catalytic triade are colored yellow in figure 23. 
Two possible acid protease active sites can 
also be found in the structure. It is much harder 
to predict the existence and position of an acid 
protease active site since only two aspartic 
acid residues are needed to for the active site 
of an acid protease.  
4.5.2 Comparison to unknown 
proteins 
A BLAST search with the Endo T sequence 
(using the BLAST server at Uniprot) against 
eukaryotic similar enzymes was carried out to 
compare Endo T to non-structural 
characterized homologous proteins. The Blast 
results of the BLAST search are shown in 
appendix 5. After the BLAST search, the 
identified sequences that had the highest 
similarity in amino acid sequence and function 
(ENGases) were selected and aligned. A 
genealogic tree and amino acid sequence 
alignment were generated from this. The 
genealogic tree is shown in appendix 6, a part 
of the alignment is shown in appendix 7. This 
part contains both the ENGase active site and 
the possible serine protease active site. In the 
alignment only the six first sequences contain 
both the serine and histidine residue in the 
potential protease active site of these proteins, 
this is shown in Figure 24. Endo FV (F. 
velutipes) was also included in the alignment, 
but lacks both the serine and histidine residue 
of the potential serine protease active site, 
while most of the proteins have the histidine 
residue. The other proteins, which were used 
in the sequence alignment are shown in 
appendices 5 to 7. 
 
Figure 24: BLAST results, which could, just as Endo 
T have a possible protease active site. Serine and 
threonine residues are shown in green.  
The proteins, which have both the ENGase 
active site and the possible serine protease 
active site, come from Metarhizium acridum 
(ENGase, E9EFP8), Metarhizium robertsii 
(ENGase, E9F659), Trichoderma reesei 
24 
 
(ENGase, C4RA89), Magnaporthe oryzae 
(unknown function, A4RJB3), Sordaria 
macrospora (unknown function, D1ZGL1) and 
Podospora anserine (unknown function, 
B2AES6). All of these organisms are 
filamentous fungi. The protein from 
Magnaporthe oryzae has a threonine residue 
instead of a serine residue. 
4.6 Possible protease active 
site 
Since the structure of the active Endo T was 
already solved, it was checked for a possible 
protease active site. There were no free 
cysteine residues, which would exclude a 
potential cysteine proteases. One possible 
serine protease site was found, close to the 
ENGase active site. Two possible acid 
protease sites were also found, but after 
checking the structure one was excluded. 
Since the proteolysis occurs without any 
metals in the protein sample we can also 
exclude a possible metallo protease activity. 
Other protease activities are more specific and 
too difficult to screen in an alignment or a 
known structure. There is though no direct 
proof yet that Endo T actually possesses both 
ENGase and protease activity. 
4.6.1 Serine protease 
The possible serine protease (SP) active site 
consists of Ser 44, His 46 and possibly Asp 57 
and Gly 87. This possible SP (colored blue in 
figure 25) site is located right next to the 
ENGase active site (colored red in figure 25). 
In between these two possible activity sites of 
Endo T is the loop going from β -sheet to α -
helix 3, which forms some sort of barrier 
between the ENGase active site of Endo T and 
the potential serine protease active site of the 
enzyme.  
In the ligand structure of Endo T, there were 
interactions between His 46 and the branching 
Man. The suggested Asp also interacted with 
this Man. There were no interactions with other 
residues in the protein. Figure 26 is the 
catalytic site of the protease trypsin a serine 
protease from pig (PDB code 1AN1). There are 
differences in distance and conformation 
between the amino acids building up the 
catalytic site of the trypsin protease and the 
amino acids building up the possible serine 
protease active site of Endo T. This difference 
between the active site of the two enzymes 
might be due to crystal packing interactions 
causing changes in the position of the potential 
catalytic amino acids of the two compared 
structures. 
 
Figure 25: The possible serine protease active site 
(blue) positioned next to the ENGase active site 
(red) of Endo T. The cartoon representation of Endo 
T was made from the Endo T structure with a ligand 
bound in the enzyme at pH 3. 
 
Figure 26: Cartoon representation of the pig trypsin 
protease catalytic site with the catalytic residues 
H56, D102 and S196 colored in red. 
4.6.2 Acid protease 
Two aspartic acids are needed in the active 
center of an acid protease (AP). After going 
through the sequence alignment and structure 
of Endo T, only one potential active site had 
two Aspartate residues in a conformation 
where the distances between these two 
residues could build up an AP active site. The 
two amino acids that potentially could build up 
an AP active site are Asp 202 and Asp 205. 
Figure 27 shows Endo T in green with the 
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previously described SP active site in blue, the 
ENGase active site in red and the AP active 
site in orange compared to the structure of 
Endo F3 in yellow. The Asp residues are not 
conserved in the known structures from the GH 
18 family, nor in the unknown proteins 
identified in the BLAST search.  
 
Figure 27: Cartoon representation of Endo T 
superimposed on Endo F3 in yellow, showing the 
possible acid protease active site in orange with Asp 
202 and Asp 205 in α -helix 6 of Endo T. The 
ENGase active residues are shown in red, the 
previously described serine protease residues in 
blue. 
5 Discussion 
5.1 Biochemical 
characterization 
5.1.1 C-terminal stability  
The proteolytic cleavage of the C-terminus is 
both influenced by temperature and pH. With 
the addition of a protease inhibitor cocktail we 
are able to inhibit the proteolytic cleavage, 
except at very low pH. The bachelor student 
Jason Blomme did a more extent biochemical 
characterization (Blomme 2011). He showed 
that at pH 5 and pH 8 Endo T stays intact for 
more than 10 days, when the protease inhibitor 
cocktail is added. This control failed in the first 
experiments which were carried out. The 
protein samples were stored in the freezer, 
where the protease inhibitor cocktail is not 
stable. Therefore the protease inhibitor cocktail 
should be added fresh, before each incubation. 
At pH 5 the proteolysis is enhanced when the 
intact Endo T is stored at a higher temperature. 
When we lower de pH at 21°C the proteolysis 
is also enhanced. Especially at pH 3 and 
lower, here complete degradation happens 
within a day and the protease inhibitor cocktail 
is not working. The inhibitor might not be stable 
at this pH or the protease activity is enhanced 
in such extent that the concentration of the 
inhibitor is insufficient. This posed big 
problems for the crystallization experiments, 
since the only crystallization condition of the 
active Endo T, which gave crystals for the 
intact Endo T was at pH 3 and lower. The 
protein in this crystal was therefore the 
processed Endo T and not the intact Endo T. 
This was verified on SDS-PAGE. This pushed 
us to screen for more crystallization conditions 
especially at higher pH. Three different 
crystallization conditions were found, two at pH 
6.5 and one at pH 7.5. The actual pH was 
checked with a pH-strip and was lower than pH 
5. The so called higher pH crystallization 
condition was also the processed Endo T. This 
was confirmed by SDS-PAGE and the crystals 
had the same shape as the previous crystals 
from the active Endo T. 
5.1.2 Deglycosylation 
The intact Endo T was incubated at 37 °C with 
protease inhibitors to let the active fraction of 
the unpurified Endo T sample deglycosylate 
the intact fraction. Deglycosylated proteins are 
easier to crystallize, a second reason for 
performing this experiment, was to see if the 
deglycosylation and proteolysis are linked or if 
they take place separately. We can conclude 
that deglycosylation and proteolysis are linked 
in fact. After the deglycosylation we had two 
bands on SDS-PAGE. If they would not be 
linked, we would only expect one, the 
completely deglycosylated Endo T with his C-
terminus. Since two bands are detected, it 
seems that only one of the two glycosylation 
sites was deglycosylated. This was also 
confirmed by the experiments, which Jason 
Blomme carried out (Blomme 2011). He 
suggested that Asn 240, which is close to the 
cleavage site of the C-terminus, is not as 
accessible as the Asn 70. 
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5.2 Protease activity 
Endo T gets very fast processed, especially at 
very low pH. The proteolytic cleavage of 
proteins has been described both in T. reesei 
and P. pastoris. We knew this could pose huge 
problems, even after purification. Therefore it 
could be that Endo T could have a protease 
activity. In a previous article from Eneyskaya et 
al. an acid protease from T. reesei. was 
described (Eneyskaya, et al. 1999). The 
protein they describe has the same molecular 
weight as Endo T and behaves in the same 
way, as problems we encounter when we try to 
keep Endo T intact. Their protease activity 
increased massively when the pH was lower 
than pH 3. They were able to inhibit the 
protease activity at this low pH, but only when 
equimolar quantities of pepstatin were added 
to the protease. Cel7A was one of the 
substrates Eneyskaya et al. tried for this acid 
protease. After incubating Endo T with Cel7A 
for two hours at different enzyme/substrate 
ratios, no proteolytic cleavage was detected. 
One possible serine protease active site was 
found when the structure was screened. 
5.3 Endo T structure 
We tried to crystallize the intact Endo T, but we 
were not able to suppress the proteolysis. 
Several structures were solved at different 
pH’s. Two models were refined to compare the 
structure of Endo T at low and more neutral 
pH. 
  
Figure 28: Comparison of the N-terminus for the 
different Endo T structures at different pH. In green 
the Endo T structure at pH 7.5 and in blue the Endo 
T structure at pH 3. 
5.3.1 N-terminus 
There were no big differences in the structure, 
except at the N-terminus. Endo T was 
expressed in P. pastoris and since we used a 
construct, four more amino acids (EAEA) are 
found at the N-terminus. As is shown in figure 
30, the orientation of the N-terminus changed. 
The longer N-terminus goes towards the 
ENGase active site of another Endo T 
molecule in the crystal structure. This did not 
change in the structure of Endo T at pH 7.5, 
where the four extra amino acids were not 
detected in the electron density map. The 
crystal at pH 3 had a different form 
(tetrahedral) then the crystal in the other 
crystallization conditions (cubic). Therefore it is 
possible that due to the pH and maybe 
enhanced protease activity, the N-terminus is 
folding to the molecule next to it. We don’t 
know if the structure at pH 7.5 lacked these 
four amino acids or that the N-terminus was to 
floppy to be seen in the electron density map. 
5.3.2 C-terminus 
Since we were not able to control the 
proteolysis, we were not able to solve the 
structure of the intact Endo T. Previously was 
shown that Endo T becomes active when it is 
both deglycosylated and proteolytic cleaved. 
Where the proteolytic cleavage is the main 
drive for activation. This activation is strongly 
pH dependent. There are two hypotheses why 
the intact Endo T is inactive. The 47 amino 
acid long C-terminus could fold back to the top 
of the (β/α)8 TIM barrel. A second hypothesis is 
that the C-terminus induces conformational 
changes in the helices that disturb the ENGase 
active site at the top of the (β/α)8 TIM barrel. 
When we look at figure 31 the C-terminus is 
colored dark orange and could fold back 
towards the active site. There is more room in 
between the α-helices at the C-terminus then 
there is between the other α-helices. Whether 
the C-terminus would fold back between the 
dark orange and shorter helix or between the 
shorter and light orange helix is not clear, both 
options could be possible. In figure 32 we can 
see that there is direct access to the active 
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site. When we even look closer at figure 33, we 
can imagine that when the C-terminus folds 
back, the substrate might not be able to reach 
the active site, since it might be hindered by 
the C-terminus. The second hypothesis is that 
the C-terminus could induce conformational 
changes in one of the three helices shown on 
figures 31 to 33. The short middle helix, has a 
very long loop at the top. If the C-terminus 
would change the conformation of this middle 
helix, the loop could have a very big influence 
on the active site. Whether it would change the 
conformation of Asp 129 and Glu 131 or 
whether it would block the substrate binding is 
again a pure guess. The right, light orange 
helix in figure 31 is directly connected to the 
possible serine protease site. Conformational 
changes in this helix could alter the 
conformation of the Ser and His forming a 
serine protease active site. The helix to the 
right of the light orange helix in figure 31 is not 
parallel with the other helices. This helix is 
turned over approximately 45 °. 
5.1 Concluding remarks 
We can conclude that due to the fact that we 
could not keep the proteolytic cleavage under 
control, the structure of the intact Endo T was 
not solved. Few hypotheses could be made on 
how the intact Endo T might be activated, but 
there is no new direct proof supporting these 
hypotheses. The C-terminus is stable at pH 5 
for 6 days, without any inhibitors. At pH 3 it 
gets processed within 2 hours and is 
completely processed within the day. This 
poses a perpetual problem to solve the 
structure. One hypothesis, is that Endo T could 
have protease activity. Therefore we tested 
Endo T for protease activity and screened its 
structure for a possible protease active site. A 
possible serine protease active site has been 
found close to the ENGase active site. The 
activity of this site might be influenced by the 
C-terminus itself, since it is so close to the 
ENGase active site. This and a previous article 
describing an acid protease from T. reesei, 
which has the same molecular weight as Endo 
T, suggested us that Endo T could have a 
protease activity. 
 
Figure 29: Side view of the short C-terminus. The 
ENGase active residues are colored red, the 
possible SP residues are colored blue.  
 
Figure 30: Side top view of the short C-terminus. 
The ENGase active residues are colored red, the 
possible SP residues are colored blue. 
 
Figure 31: Top view of the short C-terminus. The 
ENGase active residues are colored red, the 
possible SP residues are colored blue and the 
ligand NAG-Man4 is in yellow. 
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The protease activity should be tested at lower 
pH and longer incubation time to determine if 
Endo T has a protease activity. The specific 
protease activity should be determined, new 
protease inhibitors or higher concentration of 
inhibitors should be tested to inhibit the 
protease activity. This might control the 
proteolysis and help to solve the structure of 
the intact Endo T. Specific mutations could 
then be made in the suggested protease active 
sites when the specific protease activity has 
been found and to determine if the proteolytic 
cleavage of the intact Endo T is due to itself or 
another protease.  
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8 Appendix 
8.1 Appendix 1: Bio-Rad assay results 
 
 
Figure 32: BSA standard curve for total protein concentration. 
Table 7: Unpurified Endo T total protein concentrations. 
Endo T Without inhibitors Endo T With inhibitors 
dilution absorbance concentration absorbance concentration 
10 0,314 3,143  0,887 8,868 
20 0,126 2,529  0,505 10,095 
50    0,185 9,259 
      
 average concentration average concentration 
  2,836   9,407 
 
8.2 Appendix 2: Purified protein concentrations 
 
Table 8: Purified Endo T protein concentrations. 
Fraction Q1F1 Q2F1 Q1F2 Q2F2 
Absorbance 19.81 8.56 14.46 5.68 
Concentration (mg/ml) 13.76 5.94 10.00 3.94 
Final volume < 500 µl ± 750 µl ± 200 µl  ± 750 µl 
260/280 value 0.68 0.68 0.71 0.65 
QxFy; x stands for the batch, while the y stands for the peak collected. 
  
y = 0.945x + 0.063 
R² = 0.99706 
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8.3 Appendix 3: Western blot SDS-PAGE 
 
 
Figure 33: First SDS-PAGE for western blot. 
 
Figure 34: Second SDS-PAGE for western blot. 
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8.4 Appendix 4: Structural comparison of known endo-β-D-glucosaminidases 
 
 
Figure 35: Structural comparison of known endo-β-D-glucosaminidases. 
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8.5 Appendix 5: Endo T eukaryotic blast results 
 
 
Figure 36: Endo T eukaryotic blast results. 
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8.6 Appendix 6: Genealogic tree from Endo T BLAST results 
 
 
 
 
 
 
 
Figure 37: Genealogic tree from Endo T BLAST results. 
8.7 Appendix 7: Sequence alignment from Endo T BLAST results 
 
Figure 38: Sequence alignment from Endo T BLAST results. 
